Showing results (1-10 of 1,749) with videos related to
Sort By:
Pageof 175
British Journal of Clinical Pharmacology|March 1, 1997
The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptidesG McDowell, W Coutie, C Shaw, et al.European Journal of Clinical Investigation|April 1, 1997
Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjectsI C Steele, G McDowell, A Moore, et al.European Heart Journal|February 22, 2000
Is the secretion of atrial natriuretic peptide in man under neural control?G McDowell, M Cave, A Bainbridge, et al.European Journal of Clinical Investigation|August 23, 2002
Variability of Nt-proANP and C-ANPG McDowell, C Patterson, S Maguire, et al.Expert Opinion on Investigational Drugs|July 5, 2005
The endopeptidase inhibitor, candoxatril, and its therapeutic potential in the treatment of chronic cardiac failure in manG McDowell, D P NichollsBasic Research in Cardiology|January 1, 1996
Neuroendocrine changes in chronic cardiac failureD P Nicholls, G N Onuoha, G McDowell, et al.Regulatory Peptides|October 1, 1983
Intact neurotensin (NT) in human plasma: response to oral feedingC Shaw, K D BuchananEuropean Heart Journal|October 1, 1992
Regulatory peptides in the plasma of patients with chronic cardiac failure at rest and during exerciseD P Nicholls, M Riley, J S Elborn, et al.The Histochemical Journal|December 1, 1999
Calcitonin gene-related peptide, neuropeptide Y and atrial natriuretic peptide distribution in guinea pig heart from paraffin wax-embedded and formalin-cryoprotected tissuesG N Onuoha, E K Alpar, D P Nicholls, et al.International Journal of Cardiology|August 12, 1998
Extraction of human alpha atrial natriuretic peptide and its physiological validationG N Onuoha, C Shaw, D P NichollsPageof 175